Propionic Acid

Propionic Acid

SCHEMBL406808

CCC(=O)O.CCC(=O)O.CCCC(O)O

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR3 O14843 2/20 0.56
HDAC1 Q13547 2/20 0.48
HDAC2 Q92769 2/20 0.48
CHRM1 P11229 1/20 0.48
AKR1A1 P14550 1/20 0.48
CHRM3 P20309 1/20 0.48
HTR2A P28223 1/20 0.48
HTR2C P28335 1/20 0.48
ADRA1A P35348 1/20 0.48
HRH1 P35367 1/20 0.48
DRD3 P35462 1/20 0.48
SLC6A3 Q01959 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
GPR84 Q9NQS5 7/20 0.41
HDAC8 Q9BY41 2/20 0.41
HDAC3 O15379 1/20 0.41
FFAR1 O14842 2/20 0.40
CYP3A4 P08684 2/20 0.40
TSHR P16473 2/20 0.40
NFKB1 P19838 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propionic Acid SCHEMBL28468420 1.00 FFAR3 (0.56) FFAR3HDAC1HDAC2CHRM1AKR1A1
Bicarbonate SCHEMBL10590002 0.88 HDAC1 (0.52) FFAR3HDAC1HDAC2CHRM1AKR1A1
Bicarbonate SCHEMBL14562444 0.88 HDAC1 (0.52) FFAR3HDAC1HDAC2CHRM1AKR1A1
Succinic Acid SCHEMBL28438549 0.86 HDAC1 (0.52) FFAR3HDAC1HDAC2CHRM1AKR1A1
Succinic Acid SCHEMBL28210913 0.86 HDAC1 (0.52) FFAR3HDAC1HDAC2CHRM1AKR1A1
Succinic Acid SCHEMBL4667877 0.86 HDAC1 (0.52) FFAR3HDAC1HDAC2CHRM1AKR1A1
Malonic Acid SCHEMBL28697215 0.86 LDHA (0.47) FFAR3HDAC1HDAC2CHRM1AKR1A1
Acetic Acid SCHEMBL11353075 0.86 CHRM1 (0.50) FFAR3HDAC1HDAC2CHRM1AKR1A1
Oxalic Acid SCHEMBL28869438 0.86 CHRM1 (0.50) HDAC1HDAC2CHRM1AKR1A1CHRM3
Oxalic Acid SCHEMBL28066761 0.86 CHRM1 (0.50) HDAC1HDAC2CHRM1AKR1A1CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0349301-A2 Positive-type photoresist composition MITSUBISHI KASEI CORPORATION (JP) 1990-01-03 EP claimed
CN-110305433-A A kind of shock resistance acryl plates and preparation method thereof 深圳市海枫茂光学科技有限公司 2019-10-08 CN disclosed
EP-2415847-B1 METHOD FOR PRODUCING ALUMINIUM OXIDE PHOSPHOR UNIV HIROSHIMA (JP) 2014-12-31 EP disclosed
CN-103800300-A Methods of reducing alcohol-induced dose dumping for opioid sustained release oral dosage forms ALZA CORP 2014-05-21 CN disclosed
US-8652358-B2 Aluminum oxide phosphor and method for producing the same HIROSHIMA UNIVERSITY (JP) 2014-02-18 US disclosed
EP-2415847-A1 ALUMINUM OXIDE PHOSPHOR AND METHOD FOR PRODUCING SAME Hiroshima University (JP) 2012-02-08 EP disclosed
US-20120018675-A1 ALUMINUM OXIDE PHOSPHOR AND METHOD FOR PRODUCING THE SAME KURARAY CO., LTD. (JP) 2012-01-26 US disclosed
CN-1892926-B Conductive paste for multilayer electronic component and multilayer electronic component using the same SHOEI CHEMICAL IND CO 2010-07-14 CN disclosed
CN-101351202-A Method of reducing alcohol-induced dose dumping of opioid sustained release oral dosage forms ALZA CORP (US) 2009-01-21 CN disclosed
CN-101232868-A Combination of tramadol and substances that comprise gabapentin ALZA CORP (US) 2008-07-30 CN disclosed
CN-1901879-A Administration of levodopa and carbidopa ALZA CORP (US) 2007-01-24 CN disclosed
CN-1892926-A Conductive paste for multilayer electronic component and multilayer electronic component using the same SHOEI CHEMICAL IND CO (JP) 2007-01-10 CN disclosed
CN-1684670-A Methods and dosage forms for controlled delivery of paliperidone ALZA CORP (US) 2005-10-19 CN disclosed
CN-1671358-A Dosage forms and compositions for osmotic delivery of variable dosages of oxycodone ALZA CORP (US) 2005-09-21 CN disclosed
CN-1665482-A Methods and dosage forms for controlled delivery of oxycodone ALZA CORP (US) 2005-09-07 CN disclosed
CN-1620281-A Formulation & dosage form for the controlled delivery of therapeutic agents ALZA CORP (US) 2005-05-25 CN disclosed
CN-1161101-C Conversion of liquid filled gelatin capsules into controlled release systems by multiple coatings 2004-08-11 CN disclosed
CN-1331580-A Conversion of liquid-filled gelatin capsules into controlled release systems with multiple coatings ALZA CORP (US) 2002-01-16 CN disclosed
CN-1325301-A Controlled delivery of active agents ALZA CORP (US) 2001-12-05 CN disclosed
EP-0349301-A2 Positive-type photoresist composition MITSUBISHI KASEI CORPORATION (JP) 1990-01-03 EP disclosed